These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24679922)

  • 61. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H; Farde L
    Neuroimage; 2001 Oct; 14(4):936-45. PubMed ID: 11554812
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D
    Torrisi SA; Salomone S; Geraci F; Caraci F; Bucolo C; Drago F; Leggio GM
    Front Pharmacol; 2017; 8():710. PubMed ID: 29046641
    [No Abstract]   [Full Text] [Related]  

  • 63. Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [
    Grachev ID; Meyer PM; Becker GA; Bronzel M; Marsteller D; Pastino G; Voges O; Rabinovich L; Knebel H; Zientek F; Rullmann M; Sattler B; Patt M; Gerhards T; Strauss M; Kluge A; Brust P; Savola JM; Gordon MF; Geva M; Hesse S; Barthel H; Hayden MR; Sabri O
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1103-1115. PubMed ID: 32995944
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride.
    Slifstein M; Suckow RF; Javitch JA; Cooper T; Lieberman J; Abi-Dargham A
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):293-304. PubMed ID: 20571519
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.
    Boateng CA; Bakare OM; Zhan J; Banala AK; Burzynski C; Pommier E; Keck TM; Donthamsetti P; Javitch JA; Rais R; Slusher BS; Xi ZX; Newman AH
    J Med Chem; 2015 Aug; 58(15):6195-213. PubMed ID: 26203768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Current Perspectives on Selective Dopamine D
    Newman AH; Xi ZX; Heidbreder C
    Curr Top Behav Neurosci; 2023; 60():157-201. PubMed ID: 35543868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO.
    Payer DE; Behzadi A; Kish SJ; Houle S; Wilson AA; Rusjan PM; Tong J; Selby P; George TP; McCluskey T; Boileau I
    Neuropsychopharmacology; 2014 Jan; 39(2):311-8. PubMed ID: 23921256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B; Diaz J; Sokoloff P
    Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain.
    Volkow ND; Fowler JS; Gatley SJ; Dewey SL; Wang GJ; Logan J; Ding YS; Franceschi D; Gifford A; Morgan A; Pappas N; King P
    Synapse; 1999 Jan; 31(1):59-66. PubMed ID: 10025684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats.
    Ginovart N; Wilson AA; Hussey D; Houle S; Kapur S
    Neuropsychopharmacology; 2009 Feb; 34(3):662-71. PubMed ID: 18688210
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopamine D
    Matuskey D; Angarita GA; Worhunsky P; Koohsari S; Gravel P; Pittman B; Gaiser EC; Gallezot JD; Nabulsi N; Huang Y; Carson RE; Potenza MN; Malison RT
    Drug Alcohol Depend; 2021 Mar; 220():108514. PubMed ID: 33454626
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.
    Choi JK; Mandeville JB; Chen YI; Grundt P; Sarkar SK; Newman AH; Jenkins BG
    Psychopharmacology (Berl); 2010 Sep; 212(1):59-72. PubMed ID: 20628733
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    Lee JY; Kim HY; Martorano P; Riad A; Taylor M; Luedtke RR; Mach RH
    Front Neurosci; 2024; 18():1380009. PubMed ID: 38655111
    [TBL] [Abstract][Full Text] [Related]  

  • 80. D3 Receptors and PET Imaging.
    Koohsari S; Yang Y; Matuskey D
    Curr Top Behav Neurosci; 2023; 60():251-275. PubMed ID: 35711027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.